Characterization of In Vitro Hemostatic Peptide Effects by Thromboelastography
Clin Appl Thromb Hemost, 2011 Aug 25
In this study, we validated a thromboelastography (TEG) method to evaluate the hemostatic effects of 3 peptides.
The first peptide is an ideal amphipathic peptide composed of 22 leucine and lysine in a ratio of 2:1. At a very low concentration, the peptide had a procoagulant effect shown by decreases in reaction time (R) and coagulation time (K) but was impaired by a decrease in maximum amplitude (MA). At higher concentrations, the peptide had an anticoagulant effect. The α angle was minimally affected by the peptide.
The second peptide is melittin derived from bee venom. Melittin showed procoagulant effects reflected by a decrease in clotting time but led to lower MA.
The third peptide derived from fibrinogen γ chain promoted hemostasis only at an optimal concentration and became anticoagulant at a higher concentration. The hemostatic mechanisms of each peptide were discussed.
Our study would facilitate further development of peptides for either hemorrhage control or thrombosis treatment.
Tuesday, September 06, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment